BioSpace News Archive

BioMidwest

Leading Medical Physics Meeting to Feature More than 40 Presentations on ViewRay’s MRIdian MRI-Guided Radiotherapy

Presentations Highlight MRIdian Clinical Experience with Real-Time On-Table Adaptive Radiotherapy at a Growing Number of Institutions Worldwide

July 10, 2019
·
5 min read
Business

Bayer Trendlines Ag Innovation Fund to Co-invest With Trendlines in New Company

Novel technology licensed from the Weizmann Institute of Science for biological solutions to treat bacterial diseases in crops

July 10, 2019
·
5 min read
Policy

Health Canada Approves Pomalyst®-Based Triplet Combination for Patients With Multiple Myeloma

POMALYST®, in combination with bortezomib and dexamethasone, provides a new medication option for patients living with multiple myeloma

July 10, 2019
·
10 min read
Lavie Bio Announces Positive 2nd Year Field Results in Its Bio-stimulant Program for Wheat

Product candidates have repeated significant yield improvement in second year spring wheat field trials across multiple locations, varieties and conditions

July 10, 2019
·
4 min read
Acerus Provides Business Update on NATESTO® - July 10, 2019

Acerus Pharmaceuticals Corporation announced an update relative to the Company’s NATESTO® business.

July 10, 2019
·
3 min read
Deals

Healthcare Startup One BioMed closes US$5M Series A Funding Round

One BioMed Pte Ltd, a Singapore-based medical diagnostics company, announced that it has closed a US$5 million Series A financing round, led by Singapore-based Biopath Ventures and US-based ARCH Venture Partners, with Enterprise Singapore’s investment arm, SEEDS Capital, also participating.

July 10, 2019
·
4 min read
Deals

STAAR Surgical to Report Second Quarter Results on July 31, 2019

STAAR Surgical Company, a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, announced that it will release financial results for the second quarter ended June 28, 2019 on Wednesday, July 31, 2019 after the market close.

July 10, 2019
·
2 min read
BioMidwest

Introducing Three New Formats for Antimicrobial Susceptibility Testing, Including New Compounds for Combatting Gram Negative and Multidrug-Resistant Infections

New microbroth dilution plates provide gold standard-level(1) minimum inhibitory concentration (MIC) accuracy using first- and second-line treatment options

July 10, 2019
·
4 min read
Business

Geneos Therapeutics Announces First Patient Dosed with its DNA-based, Neoantigen-Targeting Personalized Vaccine Technology

This is the First-in-Human Implementation for Geneos Therapeutics’ Exquisitely Personalized Immunotherapies for Cancer (GT-EPIC) Platform Clinical collaboration with Washington University

July 10, 2019
·
5 min read
Business

AtriCure to Announce Second Quarter 2019 Financial Results

AtriCure will host a conference call at 4:30 p.m. Eastern Time on Tuesday, July 30, 2019 to discuss its second quarter 2019 financial results

July 10, 2019
·
1 min read